0001209191-22-001712.txt : 20220105
0001209191-22-001712.hdr.sgml : 20220105
20220105163356
ACCESSION NUMBER: 0001209191-22-001712
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ali-Jackson Kamil
CENTRAL INDEX KEY: 0001654337
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 22511635
MAIL ADDRESS:
STREET 1: C/O ACLARIS THERAPEUTICS, INC.
STREET 2: 101 LINDENWOOD DRIVE, SUITE 400
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484-324-7933
MAIL ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-03
1
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001654337
Ali-Jackson Kamil
C/O ACLARIS THERAPEUTICS, INC.
640 LEE ROAD, SUITE 200
WAYNE
PA
19087
0
1
0
0
Chief Legal Officer
Common Stock
2022-01-03
4
M
0
3875
A
118571
D
Common Stock
2022-01-03
4
M
0
27905
A
146476
D
Common Stock
2022-01-03
4
M
0
6638
A
153114
D
Common Stock
2022-01-03
4
M
0
7100
A
160214
D
Restricted Stock Units
2022-01-03
4
M
0
3875
0.00
D
Common Stock
3875
0
D
Restricted Stock Units
2022-01-03
4
M
0
27905
0.00
D
Common Stock
34350
0
D
Restricted Stock Unit
2022-01-03
4
M
0
6638
0.00
D
Common Stock
19914
0
D
Restricted Stock Units
2022-01-03
4
M
0
7100
0.00
D
Common Stock
28400
0
D
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Represents the number of restricted stock units that were accelerated by mutual agreement between the Reporting Person and the Issuer. The balance of unvested restricted stock units, if any, were forfeited.
The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2019, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
/s/ Mark Ballantyne, Attorney-in-Fact
2022-01-05